RIZZOLIO, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.373
EU - Europa 6.045
AS - Asia 2.973
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 17
SA - Sud America 14
OC - Oceania 12
Totale 25.465
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.126
CN - Cina 2.302
IT - Italia 1.607
PL - Polonia 1.456
IE - Irlanda 651
UA - Ucraina 528
SE - Svezia 443
DE - Germania 406
GB - Regno Unito 305
CA - Canada 244
HK - Hong Kong 210
FR - Francia 176
RU - Federazione Russa 149
TR - Turchia 131
SG - Singapore 102
FI - Finlandia 85
IN - India 73
AT - Austria 47
ES - Italia 46
BE - Belgio 44
IR - Iran 35
JP - Giappone 25
NL - Olanda 25
CH - Svizzera 23
PK - Pakistan 21
VN - Vietnam 21
BJ - Benin 17
EU - Europa 17
UZ - Uzbekistan 14
GR - Grecia 13
KR - Corea 13
BG - Bulgaria 11
AU - Australia 9
ZA - Sudafrica 9
CL - Cile 8
DK - Danimarca 6
BR - Brasile 5
RO - Romania 5
SI - Slovenia 5
CZ - Repubblica Ceca 4
TH - Thailandia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BD - Bangladesh 3
MX - Messico 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
AM - Armenia 2
EG - Egitto 2
IL - Israele 2
MY - Malesia 2
NG - Nigeria 2
PT - Portogallo 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
EC - Ecuador 1
EE - Estonia 1
IQ - Iraq 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LV - Lettonia 1
NO - Norvegia 1
SC - Seychelles 1
Totale 25.465
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.154
Fairfield 2.163
Warsaw 1.448
Chandler 1.391
Ann Arbor 1.154
Houston 1.135
Ashburn 1.113
Seattle 946
Jacksonville 858
Cambridge 717
Wilmington 674
Dublin 584
Jinan 311
Mestre 280
Nanjing 248
Dearborn 228
Shenyang 218
Hong Kong 209
New York 200
Venezia 196
Andover 184
Venice 167
Beijing 164
San Mateo 151
Mülheim 149
Boston 148
Hebei 139
Izmir 129
Princeton 129
Ottawa 116
Toronto 115
San Diego 107
Boardman 96
Guangzhou 95
Hangzhou 93
Tianjin 92
Changsha 87
Zhengzhou 87
Nanchang 86
Taizhou 83
Altamura 81
Haikou 77
Taiyuan 68
Ningbo 60
Milan 57
Jiaxing 53
San Paolo di Civitate 50
Brussels 42
Redwood City 42
London 40
Vienna 36
Pune 34
Fuzhou 33
Des Moines 32
Menlo Park 31
Hefei 28
Saint Petersburg 28
Latiano 26
Washington 24
Helsinki 23
Verona 22
Bremen 21
Kunming 21
Dong Ket 20
Rome 20
Padova 18
Vicenza 18
Cotonou 17
Kilburn 17
Madrid 17
Moscow 17
Norwalk 17
Phoenix 13
Jesolo 11
Hounslow 10
Lanzhou 10
Treviso 10
Vittorio Veneto 10
Düsseldorf 9
Johannesburg 9
Palermo 9
Sofia 9
Tappahannock 9
Udine 9
Zanjan 9
Zaragoza 9
Chicago 8
Dolo 8
Portogruaro 8
Azzano Decimo 7
Chiswick 7
Den Haag 7
Martellago 7
Reggio Nell'emilia 7
Amsterdam 6
Detroit 6
Eraclea 6
Henderson 6
Islamabad 6
Qingdao 6
Totale 20.965
Salva come PNG Salva come JPEG
Nome #
Bottom-Up Synthesis of Carbon Nanoparticles with Higher Doxorubicin Efficacy 473
An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer 458
Highly conserved non-coding sequences and the 18q critical region for short stature: A common mechanism of disease? 378
Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activity on human ovarian cancer cell lines 376
pRb controls estrogen receptor alpha protein stability and activity 374
Extracellular Matrix and Colorectal Cancer: How Surrounding Microenvironment Affects Cancer Cell Behavior? 373
Biocompatible tailored zirconia mesoporous nanoparticles with high surface area for theranostic applications 365
Hyaluronan esters drive smad gene expression and signaling enhancing cardiogenesis in mouse embryonic and human mesenchymal stem cells 362
Phamacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer 347
A functional biological network centered on XRCC3: a new possible marker of chemoradiotherapy resistance in rectal cancer patients 335
Palladacyclopentadienyl complexes bearing purine-based N-heterocyclic carbenes: A new class of promising antiproliferative agents against human ovarian cancer 335
Enhanced Chemotherapeutic Behavior of Open-Caged DNA@Doxorubicin Nanostructures for Cancer Cells 328
Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects 328
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor 327
DNA nanotechnology for cancer therapy 320
A guide to PIN1 function and mutations across cancers 314
The history of nanoscience and nanotechnology: From chemical-physical applications to nanomedicine 310
The Prolyl Isomerase Pin1 Acts Synergistically with CDK2 to Regulate the Basal Activity of Estrogen Receptor α in Breast Cancer 308
Decellularized colorectal cancer matrix as bioactive microenvironment for in vitro 3D cancer research 308
Carbon-dots from sugars and ascorbic acid: Role of the precursors on morphology, properties, toxicity and drug uptake 302
4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors 299
Clinical Predictive Circulating Peptides in Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy 297
Synthesis and in-depth studies on the anticancer activity of novel palladacyclopentadienyl complexes stabilized by N-Heterocyclic carbene ligands 295
Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer 292
An effective multi-stage liposomal DNA origami nanosystem for in vivo cancer therapy 290
The anticancer activity of an air-stable Pd(i)-NHC (NHC = N-heterocyclic carbene) dimer 282
Self-Therapeutic Nanomaterials for Cancer Therapy: A Review 278
Recent advances of electrochemical and optical enzyme-free glucose sensors operating at physiological conditions 269
Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin 264
Androgen receptor serine 81 mediates Pin1 interaction and activity 254
Alterations of the Plasma Peptidome Profiling in Colorectal Cancer Progression 252
Highly Selective Salicylketoxime-Based Estrogen Receptor beta Agonists Display Antiproliferative Activities in a Glioma Model 249
MTHFR-1298 A > C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 248
A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017) 241
Gene and MicroRNA Expression Are Predictive of Tumor Response in Rectal Adenocarcinoma Patients Treated With Preoperative Chemoradiotherapy 240
The Clinical translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes 236
Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin 235
Glucose Detection Devices and Methods Based on Metal–Organic Frameworks and Related Materials 234
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold 233
Adenosine receptor ligands in clinical trials 232
The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation 231
Identification and characterization of a new reversible MAGL inhibitor 231
Epigenetic analysis of the critical region I for premature ovarian failure: Demonstration of a highly heterochromatic domain on the long arm of the mammalian X chromosome 225
Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 225
Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors 225
RB gene family: Genome-wide ChIP approaches could open undiscovered roads 223
CDK inhibitors: from the bench to clinical trials 220
Combined effects of PI3K and SRC kinase inhibitors with imatinib on intracellular calcium levels, autophagy, and apoptosis in CML-PBL cells 217
Pin1 and nuclear receptors: A new language? 216
Strategies to optimize siRNA delivery to hepatocellular carcinoma cells 215
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 212
Cyclic Ketoximes as Estrogen Receptor Selective Agonists 212
Epigenetic control of the critical region for premature ovarian failure on autosomal genes translocated to the X chromosome: A hypothesis 211
Osteopontin controls endothelial cell migration in vitro and in excised human valvular tissue from patients with calcific aortic stenosis and controls 211
Critical choices for modeling breast cancer in transgenic mouse models 210
Spatial and temporal expression of POF1B, a gene expressed in epithelia 210
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1 209
Dissecting Pin1 and phospho-pRb regulation 209
A susceptibility gene for premature ovarian failure (POF) maps to proximal Xq28 206
Palladium (0) olefin complexes bearing purine-based N-heterocyclic carbenes and 1,3,5-triaza-7-phosphaadamantane (PTA): Synthesis, characterization and antiproliferative activity toward human ovarian cancer cell lines 206
A mutation in the Rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males 205
Fluorescent carbon nanoparticles in medicine for cancer therapy 202
Identification of new fyn kinase inhibitors using a FLAP-based approach 200
Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models 200
Pharmaco-metabolomics: An emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets 199
Improved Synthesis, Anticancer Activity and Electrochemical Characterization of Unusual Zwitterionic Palladium Compounds with a Ten‐Term Coordinative Ring 199
Metabolomics biomarkers of frailty in elderly breast cancer patients 198
Emerging molecular networks in Burkitt's lymphoma 198
Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors 198
Chromosomal rearrangements in Xq and premature ovarian failure: Mapping of 25 new cases and review of the literature 194
Fluorescent molecularly imprinted nanogels for the detection of anticancer drugs in human plasma 194
Allyl palladium complexes bearing carbohydrate-based N-heterocyclic carbenes: Anticancer agents for selective and potent in vitro cytotoxicity 193
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors 191
Nanomedicine in cancer pathology 189
Supercritical CO2 extraction of natural antibacterials from low value weeds and agro-waste 189
X chromosome and ovarian failure 183
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 182
Targeting intracellular B2 receptors using novel cell-penetrating antagonists to arrest growth and induce apoptosis in human triple-negative breast cancer 178
Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors 178
Silencing of RB1 but not of RB2/P130 induces cellular senescence and impairs the differentiation potential of human mesenchymal stem cells 177
Ubiquitin-mediated protein degradation and methylation-induced gene silencing cooperate in the inactivation of the INK4/ARF locus in Burkitt's lymphoma cell lines 176
Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer's Disease 176
Fluorescent Carbon Nanoparticles in Medicine for Cancer Therapy: An Update 176
Synthesis and Antimicrobial Evaluation of Bis-morpholine Triazine Quaternary Ammonium Salts 172
Polymer-mediated delivery of siRNAs to hepatocellular carcinoma: Variables affecting specificity and effectiveness 171
Mutation analysis of two candidate genes for premature ovarian failure, DACH2 and POF1B 170
Palladium(II)-η3-Allyl Complexes Bearing N-Trifluoromethyl N-Heterocyclic Carbenes: A New Generation of Anticancer Agents that Restrain the Growth of High-Grade Serous Ovarian Cancer Tumoroids 168
Inorganic Nanoparticles for Cancer Therapy: a Transition from Lab to Clinic 163
Research highlights. Overcoming BRAF resistance to PLX4032 by AKT inhibition in PTEN-deficient melanoma cells 161
Rational development of MAGL inhibitors 161
Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer 161
Research highlights. Protein kinase D3 is the genetic sensitizer of RAF inhibitor RAF265 in melanoma cells 157
Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors 157
Upconversion-mediated Boltzmann thermometry in double-layered Bi2SiO5:Yb3+,Tm3+@SiO2hollow nanoparticles 147
Research highlights. MCL1 and FBW7 as new predictive candidate biomarkers of anti-tubulin agents 146
Impact of DNA repair gene polymorphisms on the risk of biochemical recurrence after radiotherapy and overall survival in prostate cancer 145
Cancer extracellular vesicles: Next-generation diagnostic and drug delivery nanotools 144
Sustainable triazine-derived quaternary ammonium salts as antimicrobial agents 139
Research highlights. PI3K/AKT/mTOR inhibitors would require PI3KCA-mutation analysis 138
Application of MM-PBSA methods in virtual screening 135
Totale 23.575
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.865
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.865
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.235 0 0 0 0 0 0 0 0 0 210 402 623
2019/20205.611 417 354 398 1.358 372 486 371 647 400 434 221 153
2020/20214.930 251 172 283 222 810 410 415 396 288 598 663 422
2021/20225.040 344 591 330 625 383 40 221 194 97 740 1.014 461
2022/20233.883 297 384 68 445 366 1.110 50 284 482 32 291 74
2023/20241.503 103 110 72 91 261 443 63 124 216 20 0 0
Totale 26.121